184 related articles for article (PubMed ID: 24085760)
21. Psoriasis onset with tocilizumab.
Grasland A; Mahé E; Raynaud E; Mahé I
Joint Bone Spine; 2013 Oct; 80(5):541-2. PubMed ID: 23731639
[No Abstract] [Full Text] [Related]
22. Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis.
Nardone R; Zuccoli G; Brigo F; Trinka E; Golaszewski S
Rheumatology (Oxford); 2014 Feb; 53(2):284. PubMed ID: 24191065
[No Abstract] [Full Text] [Related]
23. Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis.
Berry CE; Tsai J; Tierney A; Pickles R
Med J Aust; 2013 Apr; 198(6):331-3. PubMed ID: 23545033
[No Abstract] [Full Text] [Related]
24. Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker.
Younis S; Rimar D; Slobodin G; Rosner I
J Rheumatol; 2012 Oct; 39(10):2055-6. PubMed ID: 23028035
[No Abstract] [Full Text] [Related]
25. IL-6 inhibition and infection: treating patients with tocilizumab.
Edwards CJ
Rheumatology (Oxford); 2012 May; 51(5):769-70. PubMed ID: 21900369
[No Abstract] [Full Text] [Related]
26. Rapidly progressive malignant melanoma in a patient treated with tocilizumab.
Bonny M; Buyse V; Suys E
J Am Acad Dermatol; 2012 Aug; 67(2):e78-9. PubMed ID: 22794823
[No Abstract] [Full Text] [Related]
27. Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study.
Yazici Y; Curtis JR; Ince A; Baraf H; Malamet RL; Teng LL; Kavanaugh A
Ann Rheum Dis; 2012 Feb; 71(2):198-205. PubMed ID: 21949007
[TBL] [Abstract][Full Text] [Related]
28. [The efficacy and safety of tocilizumab combined with disease-modifying anti-rheumatoid drugs in the treatment of active rheumatoid arthritis: a multi-center, randomized, double-blinded, placebo-controlled trial].
Shi Q; Zhao Y; Bao CD; Li XF; Huang F; Zhu P; Li ZG; Gu JR; Zhang ZY; Zhao DB; Zhao SL; Jiang QD; Tian J; Zhang FC
Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):323-9. PubMed ID: 23925361
[TBL] [Abstract][Full Text] [Related]
29. A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.
Kawashiri SY; Kawakami A; Sakamoto N; Ishimatsu Y; Eguchi K
Rheumatol Int; 2012 Dec; 32(12):4023-6. PubMed ID: 20480164
[TBL] [Abstract][Full Text] [Related]
30. Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis.
Wendling D; Vidon C; Godfrin-Valnet M; Rival G; Guillot X; Prati C
Joint Bone Spine; 2013 Dec; 80(6):670-1. PubMed ID: 23618802
[No Abstract] [Full Text] [Related]
31. Rheumatoid neutrophilic dermatitis in a patient taking tocilizumab for treatment of rheumatoid arthritis.
Kubota N; Ito M; Sakauchi M; Kobayashi K
J Dermatol; 2017 Jul; 44(7):e180-e181. PubMed ID: 28342172
[No Abstract] [Full Text] [Related]
32. How FABulous is PEGgy? Certoliziumab pegol from the bench to the patients.
Aletaha D
BioDrugs; 2014 Apr; 28 Suppl 1():S3-4. PubMed ID: 24687233
[No Abstract] [Full Text] [Related]
33. Tocilizumab (Actemra) for rheumatoid arthritis.
Med Lett Drugs Ther; 2010 Jun; 52(1340):47-8. PubMed ID: 20539266
[No Abstract] [Full Text] [Related]
34. Acute sarcoidosis as parotid fever in rheumatoid arthritis under anti-tumor necrosis factor-alpha therapy.
Salvatierra J; Magro-Checa C; Rosales-Alexander JL; Raya-Alvarez E
Rheumatology (Oxford); 2011 Jul; 50(7):1346-8. PubMed ID: 21525138
[No Abstract] [Full Text] [Related]
35. [Tocilizumab as monotherapy is clinically more effective than adalimumab].
Kreutzkamp B
Med Monatsschr Pharm; 2013 Sep; 36(9):356-7. PubMed ID: 24069651
[No Abstract] [Full Text] [Related]
36. Tocilizumab-induced psoriasiform rash in rheumatoid arthritis.
Palmou-Fontana N; Sánchez Gaviño JA; McGonagle D; García-Martinez E; Iñiguez de Onzoño Martín L
Dermatology; 2014; 228(4):311-3. PubMed ID: 24942661
[TBL] [Abstract][Full Text] [Related]
37. [Case Report; Long-term treatment with etanercept induced systemic sarcoidosis in a patient with rheumatoid arthritis].
Yokoe I; Haraoka H; Yonamine T; Sato R; Nishiwaki A; Takei M
Nihon Naika Gakkai Zasshi; 2015 Apr; 104(4):769-74. PubMed ID: 26536740
[No Abstract] [Full Text] [Related]
38. Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
Suzuki T; Hirota T; Ogishima H; Umeda N; Kondo Y; Yokosawa M; Miki H; Tsuboi H; Matsumoto I; Sumida T
Int J Rheum Dis; 2015 Jan; 18(1):108-10. PubMed ID: 25294091
[No Abstract] [Full Text] [Related]
39. A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B.
Tsuboi H; Tsujii A; Nampei A; Yoshihara H; Kawano K; Takeuchi E; Shi K
Mod Rheumatol; 2011 Dec; 21(6):701-5. PubMed ID: 21626075
[TBL] [Abstract][Full Text] [Related]
40. Photosensitivity due to tocilizumab presenting with erythema multiforme-like lesions.
Hamada K; Sawada Y; Yamaguchi T; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
Eur J Dermatol; 2016 Oct; 26(5):503-504. PubMed ID: 27346710
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
